Industry: Drug Manufacturers - Specialty & Generic
CEO:Mr. Fujun Wang
Full-time employees:1328
City:Tianjin
Address:No.16, Saida North 1st Road
IPO:2010-04-23
CIK:
Website:
General Outlook
In simple terms, Tianjin Lisheng Pharmaceutical Co.,Ltd. has 182.423 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.560% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.316%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.320%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust 0.062% return, is a testament to Tianjin Lisheng Pharmaceutical Co.,Ltd.'s adeptness in optimizing resource deployment. Tianjin Lisheng Pharmaceutical Co.,Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.079%. Furthermore, the proficiency of Tianjin Lisheng Pharmaceutical Co.,Ltd. in capital utilization is underscored by a remarkable 0.070% return on capital employed.
Stock Prices
Tianjin Lisheng Pharmaceutical Co.,Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $25.08, while its low point bottomed out at $24.61. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Tianjin Lisheng Pharmaceutical Co.,Ltd.'s stock market.
Liquidity Ratios
Analyzing 002393.SZ liquidity ratios reveals its financial health of the firm.
The current ratio of 373.09% gauges short-term asset coverage for liabilities.
The quick ratio (321.95%) assesses immediate liquidity, while the cash ratio (238.51%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
373.09%
Quick Ratio
321.95%
Cash Ratio
238.51%
Profitability Ratios
002393.SZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 35.87% underscores its earnings before tax deductions.
The effective tax rate stands at 13.71%, revealing its tax efficiency.
The net income per EBT, 89.18%, and the EBT per EBIT, 113.49%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of 31.61%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
35.87%
Effective Tax Rate
13.71%
Net Income per EBT
89.18%
EBT per EBIT
113.49%
EBIT per Revenue
31.61%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 3.73, it details the span from stock purchase to revenue.
The 3 days it takes to settle debts showcases its creditor relations.
Meanwhile, a 2 cash conversion cycle and 243.11% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.
cards.indicator
cards.value
Days of Sales Outstanding
322
Days of Inventory Outstanding
162
Operating Cycle
312.45
Days of Payables Outstanding
70
Cash Conversion Cycle
242
Receivables Turnover
2.43
Payables Turnover
5.18
Inventory Turnover
2.25
Fixed Asset Turnover
1.13
Asset Turnover
0.19
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 1.35, and free cash flow per share, 1.02, depict cash generation on a per-share basis.
The cash per share value, 11.81, showcases liquidity position.
A payout ratio of 0.02 highlights the portion of earnings distributed as dividends.
Lastly, the operating cash flow sales ratio, 0.21, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
1.35
Free Cash Flow per Share
1.02
Cash per Share
11.81
Payout Ratio
0.02
Operating Cash Flow Sales Ratio
0.21
Free Cash Flow to Operating Cash Flow Ratio
0.76
Cash Flow Coverage Ratio
3.42
Short Term Coverage Ratio
3.61
Capital Expenditure Coverage Ratio
4.12
Dividend Paid and Capex Coverage Ratio
3.72
Dividend Payout Ratio
0.01
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 1.18%, highlights its total liabilities relative to assets.
With a debt-equity ratio of 0.01, we discern the balance between debt and equity financing.
The long-term debt to capitalization, 0.08%, and total debt to capitalization, 1.43%, ratios shed light on its capital structure.
An interest coverage of 240.39 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Debt Ratio
1.18%
Debt Equity Ratio
0.01
Long Term Debt to Capitalization
0.08%
Total Debt to Capitalization
1.43%
Interest Coverage
240.39
Cash Flow to Debt Ratio
3.42
Company Equity Multiplier
1.22
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 6.15, provides a glimpse into top-line earnings distributed across each share.
Net income per share, 1.97, reflects the portion of profit attributed to each share.
The book value per share, 26.70, represents the net asset value distributed per share, while the tangible book value per share, 26.17, excludes intangible assets.
cards.indicator
cards.value
Revenue Per Share
6.15
Net Income Per Share
1.97
Book Value Per Share
26.70
Tangible Book Value Per Share
26.17
Shareholders Equity Per Share
26.70
Interest Debt Per Share
0.35
Capex Per Share
-0.34
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -1.43%, indicates top-line expansion, while the gross profit growth, -3.90%, reveals profitability trends.
EBIT growth, -35.89%, and operating income growth, -35.89%, offer insights into operational profitability progression.
The net income growth, 286.54%, showcases bottom-line expansion, and the EPS growth, 286.27%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
-1.43%
Gross Profit Growth
-3.90%
EBIT Growth
-35.89%
Operating Income Growth
-35.89%
Net Income Growth
286.54%
EPS Growth
286.27%
EPS Diluted Growth
286.27%
Weighted Average Shares Growth
0.67%
Weighted Average Shares Diluted Growth
0.67%
Dividends per Share Growth
-0.66%
Operating Cash Flow Growth
-36.78%
Free Cash Flow Growth
-49.12%
10-Year Revenue Growth per Share
7.22%
5-Year Revenue Growth per Share
-25.33%
3-Year Revenue Growth per Share
-1.59%
10-Year Operating CF Growth per Share
-28.32%
5-Year Operating CF Growth per Share
27.93%
3-Year Operating CF Growth per Share
172.52%
10-Year Net Income Growth per Share
20.28%
5-Year Net Income Growth per Share
94.31%
3-Year Net Income Growth per Share
4072.11%
10-Year Shareholders Equity Growth per Share
66.16%
5-Year Shareholders Equity Growth per Share
51.63%
3-Year Shareholders Equity Growth per Share
13.22%
10-Year Dividend per Share Growth per Share
-66.54%
3-Year Dividend per Share Growth per Share
-1.24%
Receivables Growth
-24.83%
Inventory Growth
-11.48%
Asset Growth
9.25%
Book Value per Share Growth
11.99%
Debt Growth
39.83%
R&D Expense Growth
-8.98%
SGA Expenses Growth
13.55%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 3,058,847,812.2, captures the company's total value, considering both debt and equity.
Income quality, 0.58, assesses the reliability of reported earnings.
The sales, general, and administrative to revenue ratio, 0.02, gauges operational efficiency, while the research and development to revenue, 8.54%, highlights investment in innovation.
The ratio of intangibles to total assets, 2.16%, indicates the value of non-physical assets, and capex to operating cash flow, -29.46%, measures reinvestment capability.
cards.indicator
cards.value
Enterprise Value
3,058,847,812.2
Income Quality
0.58
Sales General and Administrative to Revenue
0.02
Research and Development to Revenue
8.54%
Intangibles to Total Assets
2.16%
Capex to Operating Cash Flow
-29.46%
Capex to Revenue
-5.46%
Capex to Depreciation
-91.70%
Stock-Based Compensation to Revenue
0.54%
Graham Number
34.40
Return on Tangible Assets
6.40%
Graham Net Net
9.26
Working Capital
2,192,268,450
Tangible Asset Value
4,806,504,246
Net Current Asset Value
1,969,293,520
Average Receivables
374,613,157
Average Payables
115,614,276.5
Average Inventory
187,715,515
Days Sales Outstanding
104
Days Payables Outstanding
62
Days of Inventory On Hand
130
ROIC
1.94%
ROE
0.07%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.92, and the price to book ratio, 0.92, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 3.88, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, 24.47, and price to operating cash flows, 18.52, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
0.92
Price to Book Ratio
0.92
Price to Sales Ratio
3.88
Price Cash Flow Ratio
18.52
Price Earnings to Growth Ratio
7.65
Enterprise Value Multiple
36.55
Price Fair Value
0.92
Price to Operating Cash Flow Ratio
18.52
Price to Free Cash Flows Ratio
24.47
Price to Tangible Book Ratio
1.02
Enterprise Value to Sales
2.71
Enterprise Value Over EBITDA
17.00
EV to Operating Cash Flow
14.60
Earnings Yield
7.26%
Free Cash Flow Yield
2.96%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
